(561) 802-3060 info@mri-news.com
If you have type 2 diabetes that is inadequately controlled with insulin, the SURPASS-6 Study may interest you. We are evaluating the safety and effectiveness of a once-weekly study drug compared to insulin, in patients with type 2 diabetes.
Qualified candidates will:
• be men and women 18 years of age or older
• be diagnosed with Type 2 Diabetes for at least one year
• have been treated with long acting (basal) insulin with or without other diabetic medications to control their diabetes for at least 90 days
Additional eligibility criteria also apply.
Qualified participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.
Clinical research study enrolling now
For more information:
Metabolic Research Institute Inc.
(561) 802-3060, ext. 8036